Therapeutic Effects of Biochanin A in Diabetic Myocardial Injury: Evidence from an Experimental Model

Abstract Objective Diabetic cardiomyopathy (DCM) is a diabetes-associated cardiovascular complication characterized by progressive myocardial structural remodeling and functional deterioration, representing a leading cause of diabetes-related morbidity and mortality. Biochanin A (BCA), a phytoestrogenic isoflavone derived from Trifolium pratense , exhibits pleiotropic biological activities including antidiabetic, anti-inflammatory, and antioxidant effects. This study evaluated the therapeutic effects of BCA in a streptozotocin (STZ)-induced rat model of diabetic myocardial injury. Methods Forty male Wistar albino rats were randomized into four groups: Control, BCA (20 mg/kg/day), STZ (45 mg/kg), and STZ + BCA, with BCA administered i.p. for 30 days post-induction. Cardiac stress markers (ANP, NT-proBNP), endoplasmic reticulum stress (GRP78), and apoptosis (caspase-3) were assessed via immunohistochemistry, alongside serum myocardial injury markers (CK-MB, hs-cTnT, LDH), oxidative stress parameters (SOD, CAT, MDA), and pro-inflammatory mediators (TNF-α, IL-6, NF-κB). Results BCA treatment significantly reduced hyperglycemia, increased SOD and CAT levels, decreased MDA, reduced circulating TNF-α, IL-6, and NF-κB, and lowered serum myocardial injury markers. Immunohistochemistry showed reduced ANP, NT-proBNP, GRP78, and caspase-3 immunoreactivity, accompanied by improved myocardial architecture on histopathology. Conclusion These findings suggest that BCA exerts multitarget therapeutic effects on diabetic myocardial injury, through modulation of glycemic, oxidative, inflammatory, and ER stress-related apoptotic pathways, highlighting it as a promising candidate for the management of diabetic cardiac complications.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11566445/v1
Primary Topic
Cardiac Fibrosis and Remodeling
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Therapeutic Effects of Biochanin A in Diabetic Myocardial Injury: Evidence from an Experimental Model

Emin Kaymak, Ayşe Toluk, Ali Tuğrul Akın, Tayfun Ceylan et al.
3 links
Research Square
Cardiac Fibrosis and Remodeling
preprint

Therapeutic Effects of Biochanin A in Diabetic Myocardial Injury: Evidence from an Experimental Model

Emin Kaymak, Ayşe Toluk, Ali Tuğrul Akın, Tayfun Ceylan, Şaban Varinli, Mohamed Lemine El Bechir
preprint en

Abstract

Abstract Objective Diabetic cardiomyopathy (DCM) is a diabetes-associated cardiovascular complication characterized by progressive myocardial structural remodeling and functional deterioration, representing a leading cause of diabetes-related morbidity and mortality. Biochanin A (BCA), a phytoestrogenic isoflavone derived from Trifolium pratense , exhibits pleiotropic biological activities including antidiabetic, anti-inflammatory, and antioxidant effects. This study evaluated the therapeutic effects of BCA in a streptozotocin (STZ)-induced rat model of diabetic myocardial injury. Methods Forty male Wistar albino rats were randomized into four groups: Control, BCA (20 mg/kg/day), STZ (45 mg/kg), and STZ + BCA, with BCA administered i.p. for 30 days post-induction. Cardiac stress markers (ANP, NT-proBNP), endoplasmic reticulum stress (GRP78), and apoptosis (caspase-3) were assessed via immunohistochemistry, alongside serum myocardial injury markers (CK-MB, hs-cTnT, LDH), oxidative stress parameters (SOD, CAT, MDA), and pro-inflammatory mediators (TNF-α, IL-6, NF-κB). Results BCA treatment significantly reduced hyperglycemia, increased SOD and CAT levels, decreased MDA, reduced circulating TNF-α, IL-6, and NF-κB, and lowered serum myocardial injury markers. Immunohistochemistry showed reduced ANP, NT-proBNP, GRP78, and caspase-3 immunoreactivity, accompanied by improved myocardial architecture on histopathology. Conclusion These findings suggest that BCA exerts multitarget therapeutic effects on diabetic myocardial injury, through modulation of glycemic, oxidative, inflammatory, and ER stress-related apoptotic pathways, highlighting it as a promising candidate for the management of diabetic cardiac complications.

Research Square
Yozgat Bozok Üniversitesi (TR), Cappadocia University (TR), Istinye University (TR), Erciyes University (TR)
Erciyes Üniversitesi
Good health and well-being
Cardiac Fibrosis and Remodeling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon